首页|归夏散结汤预防结直肠腺瘤术后复发的临床研究

归夏散结汤预防结直肠腺瘤术后复发的临床研究

扫码查看
目的 观察归夏散结汤预防结直肠腺瘤术后复发的临床疗效.方法 选取2022年1-7月河北省中医院收治的90例行结直肠腺瘤内镜下切除术的患者作为研究对象,采用随机数字表法将入选者分为治疗组和对照组,每组45例.2组均于术后对患者进行健康教育,指导患者规律作息、合理饮食(减少红肉摄入)、调畅情志,治疗组加服归夏散结汤治疗12周 比较2组患者术后治疗前、治疗12周临床症状评分及血清白细胞介素-6(IL-6)、前列腺素E2(PGE2)、肿瘤坏死因子-α(TNF-α)水平,评估2组治疗12周后临床疗效,并记录治疗期间不良反应发生情况;于术后1年复查肠镜,统计腺瘤复发情况以及腺瘤数量与大小.结果 治疗12周后,对照组仅黏液血便、腹胀、里急后重评分较治疗前明显降低(P均<0.05),治疗组腹痛、腹胀、黏液血便、便秘、里急后重、腹泻评分均明显低于治疗前及对照组(P均<0.05);2组血清IL-6、PGE2、TNF-α水平均较治疗前明显降低(P均<0.05),且治疗组IL-6、PGE2、TNF-α水平均明显低于对照组(P均<0.05);治疗组总有效率明显高于对照组[80.0%(36/45)比57.8%(26/45),P<0.05].2组患者在治疗期间未见严重不良反应.术后1年复查肠镜,治疗组腺瘤复发率明显低于对照组[20%(9/45)比40%(18/45),P<0.05],且治疗组腺瘤数量及最大直径均明显低于对照组(P均<0.05).结论 归夏散结汤能明显改善结直肠腺瘤术后患者症状,减轻机体炎症反应,有效预防结直肠腺瘤术后复发,且安全性好.
Efficacy of Guixia Sanjie Decoction on postoperative recurrence of colorectal adenoma
Objective It is to observe the clinical effect of Guixia Sanjie Decoction in preventing postoperative recur-rence of colorectal adenoma.Methods Ninety patients undergoing endoscopic resection of colorectal adenoma in Hebei Pro-vincial Hospital of Traditional Chinese Medicine from January to July 2022 were selected as the study objects and divided into treatment group and control group according to random number table method,with 45 cases in each group.The patients of the two groups were given health education after surgery,they were instructed to work and rest regularly,eat reasonably(reduce red meat intake),and regulate mood.Additionally,the treatment group was treated with Guixia Sanjie Decoction for 12 weeks.The clinical symptom scores and serum levels of interleukin-6(IL-6),prostaglandin E2(PGE2)and tumor necrosis factor-α(TNF-α)of the patients in the two groups before and after 12 weeks of treatment were compared,the clin-ical efficacies of the two groups after 12 weeks of treatment were assessed,and the occurrences of adverse reactions during the treatment period were recorded.The colonoscopy was reexamined in 1 year after surgery to calculate the recurrence of adenomas as well as the number and size of adenomas.Results After 12 weeks of treatment,only the symptom scores of mucous blood stools,abdominal distension,tenesmus and diarrhea were significantly decreased compared with before treat-ment in the control group(all P<0.05),the symptom scores of abdominal pain,abdominal distension,mucous blood stools,constipation,tenesmus and diarrhea in the treatment group were all significantly lower than those before treatment and in the treatment group(all P<0.05).After 12 weeks of treatment,the serum levels of IL-6,PGE2 and TNF-α were significantly lower than those before treatment in the two groups(all P<0.05),and the serum levels of IL-6,PGE2 and TNF-α in the treatment group were significantly lower than those in the control group(all P<0.05);the total effective rate of the treatment group was significantly higher than that of the control group[80.0%(36/45)VS.57.8%(26/45),P<0.05].No serious adverse reactions were observed in the two groups during the treatment period.The results of colonosco-py in one year after surgery showed that the recurrence rate of adenomas in the treatment group was significantly lower than that in the control group[20%(9/45)VS.40%(18/45),P<0.05],and the number and maximum diameter of adeno-mas in the treatment group were significantly lower than those in the control group(both P<0.05).Conclusion Guixia Sanjie Decoction can effectively improve the symptoms of patients with colorectal adenocarcinoma after surgery,alleviate their body inflammatory response,and effectively prevent the recurrence of colorectal adenoma after surgery with good safety.

colorectal adenomapostoperative recurrenceGuixia Sanjie Decoction

贾苏杰、郎晓猛、刘建平、赵源、康欣

展开 >

河北中医药大学,河北石家庄 050200

河北省中医院,河北 石家庄 050011

河北省中西医结合胃肠病研究重点实验室,河北石家庄 050011

结直肠腺瘤 术后复发 归夏散结汤

国家中医临床研究基地建设项目河北省名中医传承工作室建设项目(河北省中医药管理局)河北省中医药管理局科研计划项目

国中医药科技函[2018]131号冀中医药函[2019]86号2022073

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(11)